A study published in PubMed examines the post-marketing surveillance of adverse events related to the enterovirus type 71 inactivated vaccine in China from 2016 to 2023. The findings contribute to understanding the vaccine's safety profile in the population.
post marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in china 2016 2023
Original title: “Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023.”